Condition
Malignant Mesothelioma
Estimated Enrollment: 40
Age Group: 1 Year and older (Child, Adult, Senior)
Gender: All
Study Type: Interventional
Study Design Allocation: Primary Purpose: Treatment
Study ID Numbers: CDR0000066551|BC-MA-2
Study First Received: November 1, 1999
Last Updated: December 17, 2013
Estimated Primary Completion Date: December 2011
Primary Outcome Measures:
Response rate based on tumor measurements taken at 12 weeks|Survival at 1, 2, and 5 years from the start of treatment
Sponsors and Collaborators:
Burzynski Research Institute|National Cancer Institute (NCI)
Website Link: https://ClinicalTrials.gov/show/NCT00003508
